Efficacy and safety of the cryoballoon‐based atrial fibrillation ablation in patients aged ≥80 years
Aged, 80 and over
Male
Time Factors
Databases, Factual
Age Factors
Action Potentials
Middle Aged
Cryosurgery
Risk Assessment
3. Good health
03 medical and health sciences
Postoperative Complications
Treatment Outcome
0302 clinical medicine
Heart Rate
Recurrence
Risk Factors
Atrial Fibrillation
Humans
Female
Aged
Retrospective Studies
DOI:
10.1111/jce.14166
Publication Date:
2019-09-11T04:40:30Z
AUTHORS (13)
ABSTRACT
The prevalence of atrial fibrillation (AF) increases with age. Although the efficacy cryoballoon ablation (CB-A) in patients AF has been demonstrated, data on this CB-A elderly are limited. aim study was to evaluate 1-year and safety aged ≥80 years compared those less than 80 years.A total 49 consecutive paroxysmal (PAF) who underwent were 241 <80 years. AF-free survival rate at 1 year procedural between groups.Median (25th, 75th quartile) age 83 (82, 85) older group 68 (61, 73) younger group. At follow-up, success did not significantly differ groups. In Cox regression analysis, related recurrence. Low-voltage areas more frequently observed control (39% vs 17%; P = .01). Fluoroscopy time procedure significantly. There no significant difference occurrence transient phrenic nerve palsy. No severe complications occurred either group, including procedure-related deaths, atrioesophageal fistula, cardiac tamponade, cerebrovascular embolic events.The results our showed that for PAF is a feasible safe even patients, similar complication rates when population.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (13)
CITATIONS (16)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....